Adamas Pharmaceuticals (Adamas Pharmaceuticals) Institutional Ownership : 27.02% (As of May. 29, 2024)

View and export this data going back to 2014. Start your Free Trial

What is Adamas Pharmaceuticals Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Adamas Pharmaceuticals's institutional ownership is 27.02%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Adamas Pharmaceuticals's Insider Ownership is 3.94%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Adamas Pharmaceuticals's Float Percentage Of Total Shares Outstanding is 88.99%.

Adamas Pharmaceuticals Institutional Ownership Historical Data

The historical data trend for Adamas Pharmaceuticals's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adamas Pharmaceuticals Institutional Ownership Chart

Adamas Pharmaceuticals Historical Data

The historical data trend for Adamas Pharmaceuticals can be seen below:

	2021-01-31	2021-02-28	2021-03-31	2021-04-30	2021-05-31	2021-06-30	2021-07-31	2021-08-31	2021-09-30	2021-10-31
Institutional Ownership	27.25	43.02	31.70	30.16	30.57	30.63	28.38	28.40	27.93	27.02

Adamas Pharmaceuticals Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

Adamas Pharmaceuticals (Adamas Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Adamas Pharmaceuticals Inc (NAS:ADMS) » Definitions » Institutional Ownership

Comparable Companies

Traded in Other Exchanges

N/A

Address

1900 Powell Street, Suite 1000, Emeryville, CA, USA, 94608

Website

http://www.adamaspharma.com

Adamas Pharmaceuticals Inc discovers, develops, and sells therapies for chronic neurologic disorders. The company's approved/commercial product is GOCOVRI, an amantadine therapy for the treatment of levodopa-induced dyskinesia in patients with Parkinson's disease. It operates in one reportable segment: the development and commercialization of therapeutics targeting chronic disorders of the central nervous system. The company generates its revenues primarily from the United States.

Executives

Vijay Shreedhar	officer: Chief Commercial Officer	C/O ADAMAS PHARMACEUTICALS, INC. 1900 POWELL STREET, SUITE 1000 EMERYVILLE CA 94608
Christopher B Prentiss	officer: Chief Financial Officer	1900 POWELL STREET SUITE 750 EMERYVILLE CA 94608
Anna Richo	director	AMGEN INC., ONE AMGEN CENTER DRIVE, THOUSAND OAKS CA 91320-1799
David L Mahoney	director	SYMANTEC CORPORATION, 20330 STEVENS CREEK BLVD., CUPERTINO CA 95014
Mardi Dier	director	C/O ACELYRIN, INC., 4149 LIBERTY CANYON RD., AGOURA HILLS CA 91301
William W. Ericson	director, 10 percent owner	777 MARINERS ISLAND BOULEVARD, SUITE 550, SAN MATEO CA 94404
John A Macphee	director	C/O ADAMAS PHARMACEUTICALS, INC. 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608
Ivan M Lieberburg	director	11682 EL CAMINO REAL, SUITE 320, SAN DIEGO CA 92130
Michael Bigham	director	890 WINTER STREET, WALTHAM MA 02451
Martha J Demski	director	7770 REGENTS ROAD SUITE 113-505, SAN DIEGO CA 92122
Neil F. Mcfarlane	officer: Chief Executive Officer	C/O RETROPHIN, INC., 12255 EL CAMINO REAL, SUITE 250, SAN DIEGO CA 92130
Alfred G Merriweather	officer: Chief Financial Officer
Jennifer J Rhodes	officer: CBO, GC & Compliance Officer	C/O ADAMAS PHARMACEUTICALS INC., 1900 POWELL ST., SUITE 750, EMERYVILLE CA 94608
Gregory T Went	director, officer: Chief Executive Officer	C/O ADAMAS PHARMACEUTICALS, INC. 2200 POWELL ST, STE 220 EMERYVILLE CA 94608
Rajiv Patni	officer: Chief Medical Officer	C/O OCERA THERAPEUTICS, INC., 525 UNIVERSITY AVENUE, SUITE 610, PALO ALTO CA 94301